Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
Portfolio Pulse from Vandana Singh
Shockwave Medical Inc (SWAV) shares increased after reports of Johnson & Johnson (JNJ) potentially acquiring the company. Piper Sandler views JNJ as a strong fit due to its interest in cardiovascular devices. Medtronic (MDT) and Boston Scientific (BSX) are also considered potential bidders. SWAV's acquisition could require a substantial offer, with bids around the mid-$300s per share mentioned. Regulatory clearance is not expected to be a hurdle, suggesting a competitive bidding process could emerge.
March 27, 2024 | 8:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific's interest in Shockwave Medical as a potential acquisition target could influence its stock, aligning with its cardiology focus.
BSX's interest in acquiring SWAV could positively impact its stock by indicating strategic expansion in its cardiology and vascular portfolio.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Johnson & Johnson's interest in acquiring Shockwave Medical aligns with its strategy to expand in cardiovascular devices, potentially impacting its stock.
JNJ's strategic interest in SWAV for expanding its cardiovascular portfolio could positively impact its stock, reflecting growth and diversification.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Medtronic's potential interest in acquiring Shockwave Medical could impact its stock, given its focus on interventional cardiology.
MDT's potential bid for SWAV, given its focus on interventional cardiology, could positively impact its stock by signaling strategic growth.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Shockwave Medical's stock rose following reports of potential acquisition by Johnson & Johnson, with Medtronic and Boston Scientific also interested.
The potential acquisition by a major company like JNJ, along with interest from MDT and BSX, suggests a high valuation and competitive bidding, likely driving SWAV's stock price up in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100